United States Peripheral Vascular Devices Market Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast To 2020 Summary GlobalData's new report, "United States Peripheral Vascular Devices Market Outlook to 2020", provides key market data on the United States Peripheral Vascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Inferior Vena Cava Filters (IVCF), Peripheral Embolic Protection Devices, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloons, PTA Peripheral Drug Eluting Balloons (DEB), Renal Denervation Disposable Catheters, Aortic Stent Grafts, Vascular Grafts and Peripheral Venous Thrombectomy Devices. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Peripheral Vascular Devices market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. For further information on this report, please visit http://www.radiantinsights.com/research/united-states-peripheral-vascular-devicesmarket-outlook-to-2020 The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope
- Market size for Peripheral Vascular Devices categories - Inferior Vena Cava Filters (IVCF), Peripheral Embolic Protection Devices, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloons, PTA Peripheral Drug Eluting Balloons (DEB), Aortic Stent Grafts, Vascular Grafts and Peripheral Venous Thrombectomy Devices. - Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for the market category. - Global corporate-level profiles of key companies operating within the United States Peripheral Vascular Devices market. - Key players covered include C.R. Bard, Inc., Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Medtronic, Inc. and Covidien plc. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medicaldevices - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Table Of Content: 1 Table of Contents 2 1.1 List of Tables 9 1.2 List of Figures 11 2 Introduction 13 2.1 What Is This Report About? 13 2.2 Peripheral Vascular Devices Market Segmentation 13 2.3 Definitions of Markets Covered in the Report 14 3 Peripheral Vascular Devices Market, United States 19 3.1 Peripheral Vascular Devices Market, United States, Revenue ($m), 2005-2012 19 3.2 Peripheral Vascular Devices Market, United States, Revenue ($m), 2012-2020 21 3.2.1 Aortic Stent Grafts Market, United States, Revenue ($m), by Segment, 2005-2012 23 3.2.2 Inferior Vena Cava Filters (IVCF) Market, United States, Revenue ($m), by Segment, 2005-2012 24
3.2.3 Peripheral Embolic Protection Devices Market, United States, Revenue ($m), by Segment, 2005-2012 25 3.2.4 Peripheral Guidewires Market, United States, Revenue ($m), by Segment, 2005-2012 27 3.2.5 Peripheral Vascular Stents Market, United States, Revenue ($m), by Segment, 2005-2012 28 3.2.6 Peripheral Venous Thrombectomy Devices Market, United States, Revenue ($m), by Segment, 2005-2012 33 3.2.7 Aortic Stent Grafts Market, United States, Revenue ($m), by Segment, 2012-2020 35 3.2.8 Inferior Vena Cava Filters (IVCF) Market, United States, Revenue ($m), by Segment, 2012-2020 37 3.2.9 Peripheral Embolic Protection Devices Market, United States, Revenue ($m), by Segment, 2012-2020 39 3.2.10 Peripheral Guidewires Market, United States, Revenue ($m), by Segment, 2012-2020 41 3.2.11 Peripheral Vascular Stents Market, United States, Revenue ($m), by Segment, 2012-2020 43 To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/unitedstates-peripheral-vascular-devices-market-outlook-to-2020#tabs-4 3.2.12 Peripheral Venous Thrombectomy Devices Market, United States, Revenue ($m), by Segment, 2012-2020 49 3.3 Peripheral Vascular Devices Market, United States, Volume (Units), 2005-2012 51 3.4 Peripheral Vascular Devices Market, United States, Volume (Units), 2012-2020 53 3.4.1 Aortic Stent Grafts Market, United States, Volume (Units), by Segment, 2005-2012 56 3.4.2 Inferior Vena Cava Filters (IVCF) Market, United States, Volume (Units), by Segment, 2005-2012 58 3.4.3 Peripheral Embolic Protection Devices Market, United States, Volume (Units), by Segment, 2005-2012 60 3.4.4 Peripheral Guidewires Market, United States, Volume (Units), by Segment, 2005-2012 62 3.4.5 Peripheral Vascular Stents Market, United States, Volume (Units), by Segment, 2005-2012 64 3.4.6 Peripheral Venous Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2005-2012 69 3.4.7 Aortic Stent Grafts Market, United States, Volume (Units), by Segment, 2012-2020 71 3.4.8 Inferior Vena Cava Filters (IVCF) Market, United States, Volume (Units), by Segment, 2012-2020 73 3.4.9 Peripheral Embolic Protection Devices Market, United States, Volume (Units), by Segment, 2012-2020 75 3.4.10 Peripheral Guidewires Market, United States, Volume (Units), by Segment, 2012-2020 77 3.4.11 Peripheral Vascular Stents Market, United States, Volume (Units), by Segment, 20122020 79 3.4.12 Peripheral Venous Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2012-2020 87 3.5 Peripheral Vascular Devices Market, United States, Average Price ($), 2005-2020 89
3.6 Peripheral Vascular Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 94 3.7 Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), 20112012 95 4 Overview of Key Companies in United States, Peripheral Vascular Devices Market 97 4.1 C. R. Bard, Inc. 97 4.1.1 Company Overview 97 4.2 Boston Scientific Corporation 97 4.2.1 Company Overview 97 4.3 Abbott Laboratories 97 4.3.1 Company Overview 97 4.4 Medtronic, Inc. 98 4.4.1 Company Overview 98 4.5 Covidien plc 98 4.5.1 Company Overview 98 4.6 Cordis Corporation 98 4.6.1 Company Overview 98 4.7 AngioDynamics, Inc. 99 4.7.1 Company Overview 99 4.8 Cook Medical Incorporated 99 4.8.1 Company Overview 99 4.9 Terumo Corporation 99 4.9.1 Company Overview 99 Access Full Report: http://www.radiantinsights.com/research/united-states-peripheralvascular-devices-market-outlook-to-2020 5 Peripheral Vascular Devices Market Pipeline Products 100 6 Financial Deals Landscape 102 6.1 Acquisition 102 6.1.1 Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of CatheterBased Renal Denervation System, For Up to US$425 Million 102 6.1.2 AngioDynamics Completes Acquisition Of Vortex Medical, Endomechanical Device Developer 105 6.1.3 Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker 107 6.2 Asset Transactions 109 6.2.1 LeMaitre Vascular To Acquire Assets Of InaVein For US$2.5 Million 109 6.2.2 Acacia Acquires Seven Patent Portfolios From Medical Device Company 111 6.2.3 Acacia Research Acquires Patent For Intraluminal Device Technology 112 6.3 Debt Offerings 113 6.3.1 Teleflex Medical Prices Private Placement of Notes Due 2024 for USD250 Million 113 6.3.2 Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million 114
6.3.3 Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million 116 6.3.4 Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million 118 6.3.5 Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million 120 6.3.6 Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 122 6.3.7 Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion 124 6.3.8 Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million 126 6.3.9 Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 128 6.4 Equity Offerings 130 6.4.1 Vermillion Completes Private Placement Of Shares US$18 Million Upon Exercise Of Warrants 130 6.4.2 Vermillion Completes Private Placement Of Shares For US$13.2 Million 131 6.5 Partnerships 133 6.5.1 ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 133 6.5.2 Cordis Enters Into Distribution Agreement With TriReme Medical 134 6.6 Private Equity 135 6.6.1 Endeavour Capital Acquires Access Scientific, Maker Of Vascular Access Devices 135 6.7 Venture Financing 136 6.7.1 Shockwave Medical Raises US$12.5 Million In Series A Financing Round 136 6.7.2 Avinger Raises Funds Through Venture Financing Round 137 6.7.3 AtheroMed Raises US$4.3 Million In Venture Financing 138 6.7.4 Avinger Raises US$10.5 Million In Venture Financing 139 6.7.5 CardioFocus Raises US$11 Million In Venture Financing 140 6.7.6 AtheroMed Raises US$6 Million In Series D Financing 141 6.7.7 480 Biomedical Raises US$18 Million In Venture Financing 142 6.7.8 Cheetah Medical Raises US$14.4 Million In Extended Series C Financing 143 6.7.9 480 Biomedical Raises US$5 Million In Venture Financing 144 Request Free Sample Of This Study @ http://www.radiantinsights.com/research/unitedstates-peripheral-vascular-devices-market-outlook-to-2020#tabs-4 6.7.10 Sapheon Raises US$20 Million In Series B Financing 146 6.7.11 NexGen Medical Systems Plans To Raise US$10 Million In Series B Financing 147 6.7.12 Avinger Raises US$33 Million In Series D Financing 148 6.7.13 NexGen Medical Systems Raises US$0.5 Million In Venture Financing 149 6.7.14 Aptus Endosystems Raises US$25 Million In Series BB Financing 150 6.7.15 Access Scientific Raises US$4 Million In Venture Financing 152 7 Recent Developments 153 7.1 Corporate Communications 153 7.1.1 May 19, 2014: Medtronic Appoints Brad Lerman to Serve as Senior Vice President, General Counsel and Corporate Secretary 153 7.1.2 Apr 23, 2014: Vermillion Appoints Chairman of Board James LaFrance as President and Chief Executive Officer 153
7.1.3 Apr 01, 2014: Aptus Endosystems Appoints Dr. Bart E. Muhs as Chief Medical Officer 154 7.1.4 Mar 13, 2014: CytoSorbents to Sponsor CytoSorb Research Symposium at ISICEM 2014 154 7.1.5 Feb 10, 2014: REVA Hires Vice President, General Counsel 155 7.1.6 Jan 20, 2014: Cardiva Medical Announces Appointment of Randy Hubbell, Chief Commercial Officer 155 7.1.7 Dec 17, 2013: Vermillion Appoints Marian E. Sacco as SVP of Sales and Marketing and Chief Commercial Officer 156 7.1.8 Dec 13, 2013: Vermillion Board of Directors Elects James T. LaFrance as Chairman 157 7.1.9 Dec 07, 2013: Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia 157 7.1.10 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 159 7.1.11 Dec 05, 2013: Edwards Lifesciences Announces Appointment of CFO 162 7.1.12 Dec 04, 2013: Cook Medical Names Rob Lyles Executive Vice President 162 7.1.13 Dec 04, 2013: Mark Breedlove Named Vice President of Cook Medical's Peripheral Intervention Clinical Division 163 7.1.14 Nov 11, 2013: LeMaitre Vascular Announces Appointment of Michael Thomas to Its Board of Directors 163 Browse Our More Medical Devices Related Reports @ http://www.radiantinsights.com/catalog/medical-devices 7.1.15 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 164 7.1.16 Oct 01, 2013: Gretchen Gutman Named Vice President of Public Policy for Cook Group 165 7.1.17 Sep 25, 2013: Accellent Announces the Promotion of Jeremy Friedman to President and Chief Operating Officer for the Cardio & Vascular Business and the Appointment of Richard Johnson as Interim CFO 165 7.1.18 Sep 16, 2013: Vermillion Appoints Dr. Eric Varma to its Board of Directors 166 7.1.19 Aug 22, 2013: Nicky James Named Vice President and Global Leader of Cook Medical Aortic Intervention Clinical Division 166 7.1.20 Aug 13, 2013: Covidien launches Barrx Channel RFA Endoscopic Catheter 166 7.1.21 Aug 02, 2013: China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 167 7.1.22 Jul 23, 2013: Dean Schauer, Executive Vice President, Cardio & Vascular Group, Announces Resignation 168 7.1.23 Jul 03, 2013: Noted Interventional Radiologists Join Surefire Medical's Scientific Advisory Board 169 7.1.24 Jun 04, 2013: Cheetah Medical Appoints Chris Hutchison As CEO 169
About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com